{"entity":{"id":"nct07520006","kind":"trial","name":"Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies","aka":[],"tldr":"A phase 1/2 trial of Bexobrutideg, Venetoclax, Rituximab and Obinutuzumab in non-Hodgkin lymphoma and chronic lymphocytic leukaemia, run by Nurix Therapeutics, Inc., now recruiting.","summary":"Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies is a phase 1/2 interventional study registered as NCT07520006 by Nurix Therapeutics, Inc., with 150 participants planned, started 2026-08 and due to reach its primary completion in 2033-05. Interventions recorded: NX-5948, venetoclax, rituximab and obinutuzumab.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT07520006","url":"https://clinicaltrials.gov/study/NCT07520006"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["non-hodgkin-lymphoma","cll"],"sections":[],"technologies":[],"targets":[],"drugs":["bexobrutideg","venetoclax","rituximab","obinutuzumab"],"companies":["nurix"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT07520006","phase":"1/2","setting":"An Open-label, Multicenter Phase 1b/2 Study to Evaluate the Safety and Efficacy of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies","sponsor":"Nurix Therapeutics, Inc.","enrolled":150,"outcomes":[]},"route":"/trials/nct07520006/","neighbours":{"cancer":[{"id":"cll","kind":"cancer","name":"Chronic lymphocytic leukaemia","route":"/cancers/cll/"},{"id":"non-hodgkin-lymphoma","kind":"cancer","name":"Non-Hodgkin lymphoma (all types)","route":"/cancers/non-hodgkin-lymphoma/"}],"drug":[{"id":"bexobrutideg","kind":"drug","name":"Bexobrutideg","route":"/drugs/bexobrutideg/"},{"id":"obinutuzumab","kind":"drug","name":"Obinutuzumab","route":"/drugs/obinutuzumab/"},{"id":"rituximab","kind":"drug","name":"Rituximab","route":"/drugs/rituximab/"},{"id":"venetoclax","kind":"drug","name":"Venetoclax","route":"/drugs/venetoclax/"}],"company":[{"id":"nurix","kind":"company","name":"Nurix Therapeutics","route":"/companies/nurix/"}]}}